Glutamate, excitotoxicity and amyotrophic lateral sclerosis (original) (raw)

• Shaw PJ (1994) Excitotoxicity and motor neurone disease: a review of the evidence. J Neurol Sci 124 [Suppl]: 6–13
  PubMed Google Scholar
• Rothstein JD (1995) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 68: 7–20
  PubMed CAS Google Scholar
• Zeman S, Lloyd C, Meldrum B, Leigh PN (1994) Excitatory amino acids, free radicals and the pathogenesis of motor neuron disease. Neuropathol Appl Neurobiol 20: 219–231
  PubMed CAS Google Scholar
• Brown RH (1995) Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80: 687–692
  PubMed CAS Google Scholar
• Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439–444
  PubMed CAS Google Scholar
• Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262: 689–695
  PubMed CAS Google Scholar
• Smith RG, Hamilton S, Hofmann F, et al (1992) Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 327: 1721–1728
  PubMed CAS Google Scholar
• Appel SH, Smith RG, Engelhardt JI, Stefani E (1993) Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 118: 169–174
  PubMed CAS Google Scholar
• Young AB, Penney JB, Dauth GW, Bromberg MB, Gilman S (1983) Glutamate or aspartate as a possible neurotransmitter of the cerebral corticofugal fibres in the monkey. Neurology 33: 1513–1516
  PubMed CAS Google Scholar
• O’Brien RJ, Fischbach GD (1986) Modulation of embryonic chick motor neuron glutamate sensitivity by interneurones and agonists. J Neurosci 6: 3290–3296
  PubMed Google Scholar
• Storm-Mathisen J, Otterson OP (1988) Localisation of excitatory amino acid transmitters. In: Lodge D (ed) Excitatory amino acids in health and disease. Wiley, Chichester, pp 107–143
  Google Scholar
• Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17: 31–108
  PubMed CAS Google Scholar
• Boulter J, Hollmann M, O’Shea-Greenfield A, et al (1990) Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249: 1033–1037
  PubMed CAS Google Scholar
• Keinanen K, Wisden W, Sommer B, et al (1990) A family of AMPA-selective glutamate receptors. Science 249: 556–560
  PubMed CAS Google Scholar
• Nakanishi N, Shneider NA, Axel R (1990) A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuron 5: 569–581
  PubMed CAS Google Scholar
• Egebjerg J, Bettler B, Hermans-Borgmeyer I, Heinemann S (1991) Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature 351: 745–748
  PubMed CAS Google Scholar
• Bettler B, Egebjerg J, Sharma G, et al (1992) Cloning of a putative glutamate receptor: a low-affinity kainate binding subunit. Neuron 8: 257–265
  PubMed CAS Google Scholar
• Werner P, Voigt M, Keinanen K, et al (1991) Cloning of a putative high affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature 351: 742–744
  PubMed CAS Google Scholar
• Herb A, Burnashev N, Werner P, et al (1992) The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8: 775–785
  PubMed CAS Google Scholar
• Yamazaki M, Mori H, Araki K, et al (1992) Cloning expression and modulation of a mouse NMDA receptor subunit. FEBS Lett 300: 39–45
  PubMed CAS Google Scholar
• Meguro H, Mori H, Araki K et al (1992) Functional characterisation of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357: 70–74
  PubMed CAS Google Scholar
• Kutsuwada T, Kashiwabuchi N, Mori H, et al (1992) Molecular diversity of the NMDA receptor channel. Nature 358: 36–41
  PubMed CAS Google Scholar
• Sommer B, Seeburg PH (1992) Glutamate receptor channels: novel properties and new clones. Trends Pharmacol Sci 13: 291–296
  PubMed CAS Google Scholar
• Sommer B, Keinanen K, Verdoorn T, et al (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels in the CNS. Science 249: 1580–1585
  PubMed CAS Google Scholar
• Burnashev N, Schoepfer R, Monyer H, et al (1992) Control by asparagine residues of calcium permeability and magnesium blockade of the NMDA receptor. Science 257: 1415–1419
  PubMed CAS Google Scholar
• Hume RI, Dingledine R, Heinemann SF (1991) Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 253: 1028–1031
  PubMed CAS Google Scholar
• Pines G, Danbolt NC, Bjoras M, et al (1992) Cloning and expression of a rat brainl-glutamate transporter. Nature 360: 464–467
  PubMed CAS Google Scholar
• Kanai Y, Hediger MA (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360: 467–471
  PubMed CAS Google Scholar
• Storck T, Schulte S, Hofmann K, Stoffel W (1992) Structure, expression and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89: 10955–10959
  PubMed CAS Google Scholar
• Rothstein JD, Martin L, Levey AI, et al (1994) Localization of neuronal and glial glutamate transporters. Neuron 13: 713–725
  PubMed CAS Google Scholar
• Danbolt NC, Storm-Mathisen J, Kanner BI (1992) An [Na+−K+] coupledl-glutamate transporter purified from rat brain is localized in glial cell processes. Neuroscience 51: 295–310
  PubMed CAS Google Scholar
• Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG (1995) An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375: 599–602
  PubMed CAS Google Scholar
• Laake JH, Slyngstad TA, Haug F-MS, Ottersen OP (1995) Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J Neurochem 65: 871–881
  PubMed CAS Google Scholar
• Lucas DR, Newhouse JP (1957) The toxic effect of sodiuml-glutamate on the inner layers of the retina. Arch Ophthalmol 58: 193–204
  CAS Google Scholar
• Olney JW (1978) Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW, McGeer P (eds) Kainic acid as a tool in neurobiology. Raven, New York, pp 95–121
  Google Scholar
• Choi DW (1987) Tonic dependence of glutamate neurotoxicity in cortical cell culture. J Neurosci 7: 369–379
  PubMed CAS Google Scholar
• Miller RJ, Murphy SN, Glaum SR (1989) Neuronal Ca2+ channels and their regulation by excitatory amino acids. Ann NY Acad Sci 568: 149–158
  PubMed CAS Google Scholar
• Siesjö BK (1988) Historical overview. Calcium, ischemia and death of brain cells. Ann NY Acad Sci 522: 638–661
  PubMed Google Scholar
• Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11: 379–387
  PubMed CAS Google Scholar
• Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634
  PubMed CAS Google Scholar
• Prehn JHM, Lippert K, Krieglstein J (1995) Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury. Eur J Pharmacol 292: 179–189
  PubMed CAS Google Scholar
• Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the_N_-methyl-d-aspartate receptor when intracellular energy levels are reduced. Brain Res 451: 205–212
  PubMed CAS Google Scholar
• Riepe MW, Hor N, Ludolph AC, Carpenter DO (1995) Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience 64: 91–97
  PubMed CAS Google Scholar
• Beal MF (1993) Role of excitotoxicity in human neurological disease. Curr Opin Neurobiol 2: 657–662
  Google Scholar
• Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2: 1547–1558
  PubMed CAS Google Scholar
• Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711–760
  PubMed CAS Google Scholar
• Lees GJ (1993) Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54: 287–322
  PubMed CAS Google Scholar
• Pellegrini-Giampietro DE (1994) Free radicals and the pathogenesis of neuronal death: co-operative role of excitatory amino acids. In: Armstrong D (ed) Free radicals in diagnostic medicine. Plenum, New York, pp 59–71
  Google Scholar
• Whetsell WO, Schwartz R (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 97: 271–275
  PubMed CAS Google Scholar
• Susel Z, Engber TM, Kuo S, Chase TN (1991) Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease. Neurosci Lett 121: 234–238
  PubMed CAS Google Scholar
• Rothstein JD, Lin L, Dykes-Hoberg M, Kuncl RW (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90: 6591–6595
  PubMed CAS Google Scholar
• Monaghan DT, Bridge RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29: 365–402
  PubMed CAS Google Scholar
• Jakoi ER, Sombati S, Gerwin C, De-Lorenzo RJ (1992) Excitatory amino acid receptor activation produces a selective and long-lasting modulation of gene expression in hippocampal neurons. Brain Res 582: 282–290
  PubMed CAS Google Scholar
• Reiter RJ (1995) Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 9: 526–533
  PubMed CAS Google Scholar
• Shaw PJ, Ince PG, Johnson M, Perry EK, Candy JM (1991) The quantitative autoradiographic distribution of [3H]MK-801 binding sites in the normal human spinal cord. Brain Res 539: 164–168
  PubMed CAS Google Scholar
• Williams TL, Ince PG, Oakley AE, Shaw PJ (1996) An immunocytochemical study of the distribution of AMPA selective glutamate receptor subunits in the normal human motor system. Neuroscience 74: 185–198
  PubMed CAS Google Scholar
• Stewart GR, Olney JW, Pathikonda M, Snider WD (1991) Excitotoxicity in the embryonic chick spinal cord. Ann Neurol 30: 758–766
  PubMed CAS Google Scholar
• Estevez AG, Stutzmann J-M, Barbeito L (1995) Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motorneuron-enriched cultures. Eur J Pharmacol 280: 47–53
  PubMed CAS Google Scholar
• Shaw PJ, Chinnery RM, Ince PG (1994) [3H]d-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study. Brain Res 655: 195–201
  PubMed CAS Google Scholar
• Chinnery RM, Shaw PJ, Ince PG, Johnson M (1993) Autoradiographic distribution of binding sites for the non-NMDA receptor antagonist [3H]CNQX in the human motor cortex, brainstem and spinal cord. Brain Res 630: 75–81
  PubMed CAS Google Scholar
• Shaw PJ, Ince PG, Matthews JNS, Johnson M, Candy JM (1994)_N_-Methyl-d-aspartate (NMDA) receptors in the spinal cord and motor cortex in motor neurone disease: a quantitative autoradiographic study using [3H]MK-801. Brain Res 637: 297–302
  PubMed CAS Google Scholar
• Shaw PJ, Chinnery RM, Ince PG (1994) Non-NMDA receptors in motor neuron disease (MND): a quantitative autoradiographic study in spinal cord and motor cortex using [3H]CNQX and [3H]kainate. Brain Res 655: 186–194
  PubMed CAS Google Scholar
• Williams TL, Day NC, Ince PG, et al (1997) Calcium permeable AMPA receptors: a molecular basis for selective vulnerability in motor neurone disease. Ann Neurol (in press)
• Burnashev N, Monyer H, Seeberg PH, Sakmann B (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8: 189–198
  PubMed CAS Google Scholar
• Bettler B, Mulle C (1995) Review: neurotransmitter receptors II. AMPA and kainate receptors. Neuropharmacology 34: 123–139
  PubMed CAS Google Scholar
• Westbrook GL (1994) Glutamate receptor update. Curr Opin Neurobiol 4: 337–346
  PubMed CAS Google Scholar
• Brorson JR, Manzolillo PA, Gibbons SJ, Miller RJ (1995) AMPA receptor desensitisation predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci 15: 4515–4524
  PubMed CAS Google Scholar
• Ballerini L, Bracci E, Nistri A (1995) Desensitisation of AMPA receptors limits the amplitude of EPSP’s and the excitability of motoneurons of the rat isolated spinal cord. Eur J Neurosci 7: 1229–1234
  PubMed CAS Google Scholar
• Traynelis SF, Hartley M, Heinemann SF (1995) Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268: 873–876
  PubMed CAS Google Scholar
• McIlwain DL (1991) Nuclear and cell body size in spinal motor neurons. In: Rowland LP (ed) Advances in neurology, vol 56. Raven, New York, pp 67–74
  Google Scholar
• Lee MK, Cleveland DW (1996) Neuronal intermediate filaments. Annu Rev Neurosci 19: 187–217
  PubMed CAS Google Scholar
• Shaw PJ, Chinnery RM, Thageson H, Borthwick G, Ince PG (1997) Immunocytochemical study of the distribution of the free radical scavenging enzymes Cu/Zn superoxide dismutase (SOD1), Mn superoxide dismutase (MnSOD) and catalase in the normal human spinal cord and in motor neuron disease. J Neurol Sci (in press)
• Ince PG, Stout N, Shaw PJ, et al (1993) Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 19: 291–299
  PubMed CAS Google Scholar
• Mattson MP, Guthrie PB, Kater SB (1989) A role for Na+-dependent Ca++ extrusion in protection against neuronal excitototixicity. FASEB J 3: 2519–2526
  PubMed CAS Google Scholar
• Plaitakis A, Constantakakis E, Smith J (1988) The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 24: 446–449
  PubMed CAS Google Scholar
• Perry TL, Hansen S, Jones K (1987) Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 37: 1845–1848
  PubMed CAS Google Scholar
• Tsai G, Stauch-Slusher B, Sim L, et al (1991) Reductions in acidic amino acids and_N_-acetyl-aspartyl-glutamate (NAAG) in amyotrophic lateral sclerosis CNS. Brain Res 556: 151–156
  PubMed CAS Google Scholar
• Rothstein JD, Tsai G, Kuncl RW, et al (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28: 18–25
  PubMed CAS Google Scholar
• Shaw PJ, Forrest V, Ince PG, Richardson JP, Wastell HJ (1995) CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4: 209–216
  PubMed CAS Google Scholar
• Perry TL, Krieger C, Hansen S, Eisen A (1990) Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann Neurol 28: 12–17
  PubMed CAS Google Scholar
• Ferrarese L, Pecora N, Frigo M, Appollonio I, Frattola L (1993) Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol 33: 316–319
  PubMed CAS Google Scholar
• Couratier P, Hugon J, Sindou P, Vallat JM, Dumas M (1993) Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to AMPA/kainate receptors. Lancet 341: 265–268
  PubMed CAS Google Scholar
• Plaitakis A, Caroscio JT (1987) Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 22: 575–579
  PubMed CAS Google Scholar
• Iwasaki Y, Ikeda K, Kinoshita M (1992) Plasma amino acid levels in patients with amyotrophic lateral sclerosis. J Neurol Sci 107: 219–222
  PubMed CAS Google Scholar
• Rothstein JD, Martin LJ, Kuncl RW (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326: 1464–1468
  PubMed CAS Google Scholar
• Rothstein JD, Dykes-Hoberg M, Pardo CA, et al (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675–686
  PubMed CAS Google Scholar
• Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73–84
  PubMed CAS Google Scholar
• Bristol LA, Rothstein JD (1996) Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 39: 676–679
  PubMed CAS Google Scholar
• Volterra A, Trotti D, Tromba C, Floridi S, Racagni G (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14: 2924–2932
  PubMed CAS Google Scholar
• Hugon J, Vallat JM (1990) Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid. Neurosci Lett 119: 45–48
  PubMed CAS Google Scholar
• Rothstein JD, Kuncl RW (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 65: 643–651
  PubMed CAS Google Scholar
• Spencer PS, Ludolph A, Dwivedi MP, Roy DN, Hugon J, Schaumburg HH (1986) Lathyrism: evidence for role of the neuroexcitatory amino acid BOAA. Lancet II: 1066–1070
  Google Scholar
• Striefler M, Cohn DF, Hirano A, Schujman E (1997) The central nervous system in a case of neurolathyrism. Neurology 27: 1176–1178
  Google Scholar
• Cohn DF, Streifler M (1981) Human neurolathyrism, a follow-up study of 200 patients. Arch Suisse Neurol Neurochir Psychiatr 128: 151–156.
  CAS Google Scholar
• Hirano A, Llena JF, Streifler M, Cohn DF (1976) Anterior horn cell changes in a case neurolathyrism. Acta Neuropathol (Berl) 35: 277–283
  CAS Google Scholar
• Spencer PS, Nunn PB, Hugon J, et al (1987) Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237: 517–522
  PubMed CAS Google Scholar
• Duncan MW, Steele JC, Kopin IJ, Markey SP (1990) 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology 40: 767–772
  PubMed CAS Google Scholar
• Spencer PS, Allen CN, Kisby CE, Ludolph AL, Ross SM, Roy DW (1991) Lathyrism and Western Pacific amyotrophic lateral sclerosis; etiology of short- and long-latency motor system disorders. In: Rowland LP (ed) Advances in neurology, vol 56. Raven, New York, pp 287–299
  Google Scholar
• Perl TM, Bedard L, Kosatsky T, Hockin JC, Todd ECD, Remis RS (1990) An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. N Engl J Med 322: 1775–1780
  PubMed CAS Google Scholar
• Teitelbaum JS, Zatorre RJ, Carpenter S, et al (1990) Neurotoxic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. J Engl J Med 322: 1781–1787
  Article CAS Google Scholar
• Kew JJM, Leigh PN, Playford ED, et al (1993) Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 116: 655–680
  PubMed Google Scholar
• Eisen A, Pant B, Stewart H (1993) Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci 20: 11–16
  PubMed CAS Google Scholar
• Mills KR (1995) Motor neurone disease: studies of the corticospinal excitation of single motoneurons by magnetic brain stimulation. Brain 118: 971–982
  PubMed Google Scholar
• Bensimon G, Lacomblez L, Meininger V and the ALS/Riluzole study group (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330: 585–591
  PubMed CAS Google Scholar
• Lacomblez L, Bensimon G, Leigh PN, et al (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347: 1425–1432
  PubMed CAS Google Scholar
• Hubert JP, Delumeau JC, Glowinski J, Prémont J, Doble A (1994) Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br J Pharmacol 113: 261–267
  PubMed CAS Google Scholar
• Malgouris C, Daniel M, Doble A (1994) Neuroprotective effects of riluzole on_N_-methyl-d-aspartate or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci Lett 177: 95–99
  PubMed CAS Google Scholar
• Benoît E, Escande D (1991) Riluzole specifically blocks inactive Na+ channels in myelinated nerve fibers. Pflügers Arch 419: 603–607
  PubMed Google Scholar
• Debono MW, Canton T, Pradier L, Doble A, Blanchard JC (1993) Effects of riluzole on electrophysiological responses mediated by rat kainate and NMDA receptors expressed in xenopus oocytes. Eur J Pharmacol 235: 283–287
  PubMed CAS Google Scholar
• Doble A, Hubert JP, Blanchard JC (1992) Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol ond-[3H] aspartate release from cultured cerebellar granule cells. Neurosci Lett 140: 251–254
  PubMed CAS Google Scholar
• Girdlestone DA, Dupuy A, Roy-Contancin L, Escande D (1989) Riluzole antagonises excitatory amino acid evoked firing in rat facial motoneurons. Br J Pharmacol 97: 583P
• Malgouris C, Bardot F, Daniel M, et al (1989) Riluzole, a novel antiglutamate prevents memory loss and hoppocampal neuronal damage in ischaemic gerbils. J Neurosci 9: 3720–3727
  PubMed CAS Google Scholar
• Stutzmann J-M, Doble A (1994) Blockade of glutamatergic transmission and neuroprotection: the strange case of riluzole. In: Jolles G, Stutzmann JM (eds) Neurodegenerative diseases. Academic Press, New York, p 205
  Google Scholar
• Hebert T, Drapeau P, Pradier L, Dunn RJ (1994) Block of the rat brain 1A sodium channel α subunit by the neuroprotective drug riluzole. Mol Pharmacol 45: 1055–1060
  PubMed CAS Google Scholar
• Rosen DR, Siddique T, Patterson D, et al (1993) Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 362: 59–62
  PubMed CAS Google Scholar
• McCord JM, Fridovich I (1969) Superoxide dismutase. J Biol Chem 244: 6049–6055
  PubMed CAS Google Scholar
• Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59: 1609–1623
  PubMed CAS Google Scholar
• Gurney ME, Pu H, Chiu AY, et al (1994) Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 264: 1772–1775
  PubMed CAS Google Scholar
• Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92: 659–693
  Google Scholar
• Ikonomidou C, Qin Y, Labruyere J, Olney JW (1996) Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD transgenic mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 55: 211–224
  PubMed CAS Google Scholar
• Gurney ME, Cutting FB, Zhai P, et al (1996) Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39: 147–158
  PubMed CAS Google Scholar
• Shaw PJ, Ince PG, Falkous G, Mantle D (1995) Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 38: 691–695
  PubMed CAS Google Scholar
• Bowling AL, Schultz JB, Brown RH, Beal MF (1993) Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61: 2322–2325
  PubMed CAS Google Scholar
• Ince PG, Shaw PJ, Candy JM, et al (1994) Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett 182: 87–90
  PubMed CAS Google Scholar
• Bergeron C, Muntasser S, Somerville MJ, Weyer L, Percy ME (1994) Copper zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motor neurons. Brain Res 659: 272–276
  PubMed CAS Google Scholar
• Markesbery WR, Ehmann WD, Candy JM, et al (1995) Neutron activation analysis of trace elements in motor neuron disease spinal cord. Neurodegeneration 4: 383–390
  PubMed CAS Google Scholar
• Kurlander HM, Patten BM (1979) Metals in spinal cord tissue of patients dying of motor neuron disease. Ann Neurol 6: 21–24
  PubMed CAS Google Scholar
• Sillevis-Smitt PAE, Mulder TPJ, Verspaget HW, Blaauwgeers HGT, Troost D, De Jong JMBV (1994) Metallothionein in amyotrophic lateral sclerosis. Biol Signals 3: 193–197
  PubMed CAS Google Scholar
• Louwerse ES, Weverling GJ, Bussuyt PMM, Posthumus Meyjes FE, De Jong JMBV (1995) Randomized double-blind controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 52: 559–564
  PubMed CAS Google Scholar
• Schor NF (1988) Inactivation of mammalian brain glutamine synthetase by oxygen radicals. Brain Res 456: 17–21
  PubMed CAS Google Scholar